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I.

INTRODUCTION: THE OPIOID EPIDEMIC AND SPECIALIZED “OPIOID
COURTS”

It is beyond dispute that the United States is in the grip of an opioid
crisis. Statistics underscore the gravity of the problem. In 2016, of the more
than 63,000 deaths resulting from drug overdose, two-thirds involved
opioids.1 This represents a five-fold increase in opioid-related deaths from
1999,2 and the numbers keep getting worse. In 2017, preliminary data
suggested an annual increase of roughly seven percent,3 with synthetic
opioids driving the surge; in fact, the Centers for Disease Control and
Prevention estimate that nearly 30,000 of the more than 72,000 estimated
overdose deaths in 2017 were related to fentanyl or other synthetic opioids.4


Eugene Gressman Professor of Law, Seton Hall University School of Law. Many thanks to
Hafsa Mansoor, Anthony Gingerelli, and Michael Morgan for their excellent research
assistance.
1
Puja Seth et al., Quantifying the Epidemic of Prescription Opioid Overdose Deaths,
108 AM. J. PUB. HEALTH 500, 500 (2018).
2
Id.
3
Susan Scutti, U.S. Drug Overdose Deaths Rose 7% in 2017 and Doubled Over a
Decade, CDC Reports, CNN (Aug. 16, 2018), https://www.cnn.com/2018/08/16/health/usoverdose-death-report-cdc/index.html.
4
Farida B. Ahmad et al., Provisional Drug Overdose Death Counts, NAT’L CTR. FOR
HEALTH STAT., https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm (last updated

997

CORNWELL (DO NOT DELETE)

998

5/24/2019 12:42 PM

SETON HALL LAW REVIEW

[Vol. 49:997

While the opioid scourge has not discriminated geographically, the
Northeast and Midwest have been especially hard hit. For example, West
Virginia, New Hampshire, Ohio, Maryland, and Massachusetts reported the
highest opioid overdose death rates in 2016.5 The epidemic has spread most
alarmingly, moreover, in rural communities where overdose deaths have
increased at three times the rate of metropolitan areas.6 As a result, the rate
of drug overdose deaths in rural areas has now surpassed that of urban
centers.7 Commentators have attributed the disparity to various factors,
including the increased nonmedical use of prescription opioids by
adolescents, coupled with polydrug use and depression.8 The exacerbation
in rural areas also corresponds closely to the economic blight and lack of
opportunity plaguing certain groups, most notably working-class whites and
Native Americans.9
As panic has mounted, lawmakers have scrambled to respond to a
national call for action. In 2016, Congress provided $1 billion over a twoyear period (2017-2018)10 for a variety of opioid-based needs relating to
treatment services, provider training, and public outreach, among others.11
The Substance Use-Disorder Prevention that Promotes Opioid Recovery and
Treatment for Patients and Communities Act (SUPPORT), signed into law
in October 2018,12 will provide additional support, and Congress has
appropriated $8.5 billion to fund opioid-related programs.13
Apr. 17, 2019); Andrew D. Bowser, CDC: 2017 Worst Year Yet for Drug Overdoses,
HOSPITALIST (Aug. 17, 2018), https://www.the-hospitalist.org/hospitalist/article/172906/addi
ction-medicine/cdc-2017-worst-year-yet-drug-overdoses (“Deaths attributable to synthetic
opioids have . . . soar[ed] from just 9,983 in 2015 to 20,310 in 2016, and to 29,418 in 2017.”).
5
See Opioid Overdose Death Rates and All Drug Overdose Death Rates per 100,000
Population (Age-Adjusted), 2017, KAISER FAM. FOUND., https://www.kff.org/other/stateindicator/opioid-overdose-death-rates/?currentTimeframe=0&sortModel=%7B%22colId%2
2:%22Location%22,%22sort%22:%22asc%22%7D (last visited May 10, 2019).
6
Katherine M. Keyes et al., Understanding the Rural–Urban Differences in
Nonmedical Prescription Opioid Use and Abuse in the United States, 104 AM. J. PUB. HEALTH
e52, e52 (2014).
7
66 KARIN A. MACK ET AL., CTRS. FOR DISEASE CONTROL & PREVENTION, MORBIDITY
AND MORTALITY WEEKLY REPORT: ILLICIT DRUG USE, ILLICIT DRUG USE DISORDERS, AND
DRUG OVERDOSE DEATHS IN METROPOLITAN AND NONMETROPOLITAN AREAS–UNITED STATES
1 (2017), https://www.cdc.gov/mmwr/volumes/66/ss/pdfs/ss6619.pdf.
8
See Jennifer R. Havens et al., Nonmedical Prescription Drug Use in a Nationally
Representative Sample of Adolescents: Evidence of Greater Use Among Rural Adolescents,
165 ARCHIVES PEDIATRICS & ADOLESCENT MED. 250, 253–54 (2011).
9
See Leo Beletsky, 21st Century Cures for the Opioid Crisis: Promise, Impact and
Missed Opportunities, 44 AM. J. L. MED. & ETHICS 359, 360 (2018).
10
See 21st Century Cures Act, Pub. L. No. 114-255, § 1003, 130 Stat. 1033, 1044–46
(2016).
11
Id. § 1003(c)(2).
12
Pub. L. No. 115-271, §§ 1010–11, 132 Stat. 3894, 3918–19 (2018).
13
Colby Itkowitz, Senate Easily Passes Sweeping Opioids Legislation, Sending to
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Local law enforcement has also been innovative in managing offenders
suffering from opioid addiction. The Police Assisted Addiction & Recovery
Initiative (PAARI) is perhaps the highest profile—and most successful—
such effort. First introduced by the Gloucester, Massachusetts Police
Department in 2015, PAARI is a non-profit organization that promotes
pathways to treatment for addicts upon their initial contact with local
police.14 By 2017, roughly two hundred police agencies in twenty-eight
states had joined PAARI.15 The Lodi Police Department in Ohio is among
them, joining the “Safe Passages” program that works with PAARI to place
addicts into treatment the moment they turn up at the police station and
surrender their drugs. As Lodi Police Corporal David Brantner noted, the
program endeavors to stop the “the revolving door” of crime and addiction.16
The Cuyahoga County Prosecutor, Timothy McGinty, agrees, adding that
“[w]e are not going to prosecute our way out of this mess.”17
The foregoing provides a backdrop for a provocative initiative that is
garnering national attention: specialized “opioid courts.” Members of the
judiciary have joined legislators and law enforcement officials in looking for
innovative ways to combat the opioid crisis. In May 2017, Buffalo City
Court Judge Craig D. Hannah established the first-ever Opiate Crisis
Intervention Court courtesy of a three-year, $300,000 U.S. Department of
Justice grant.18 From 2015 to 2016, Buffalo had seen opioid deaths more
than double to about 300, with further increases expected.19 The judge’s goal
President Trump, WASH. POST (Oct. 3, 2018), https://www.washingtonpost.com/politics/2018
/10/03/senate-is-poised-send-sweeping-opioids-legislation-president-trump/?utm_term=.6b7
e64836924. Critics of SUPPORT have argued that, while laudatory, this additional funding
falls woefully short of the resources necessary to meaningfully address the opioid crisis.
Democrats Elizabeth Warren and Elijah Cummings proposed the Comprehensive Addiction
Resources Emergency (CARE) Act, an alternative bill that would provide $100 billion over
ten years to prevent and treat substance use disorders. “We can’t defeat the opioid crisis,”
Senator Warren stated, “with empty words and half measures.” Rachel Roubein, Warren,
Cummings Seek $100B to Fight Opioid Epidemic, HILL (Apr. 18, 2018),
https://thehill.com/business-a-lobbying/383787-warren-cummings-seek-100b-to-fightopioid-epidemic.
14
About Us, PAARI, https://paariusa.org/about-us/ (last visited May 10, 2019).
15
Brian MacQuarrie, ‘Angel’ Opioid Initiative Thrives Despite Exit of Gloucester Police
Chief, BOS. GLOBE (Feb. 21, 2017), https://www.bostonglobe.com/metro/2017/02/21/angelopioid-initiative-thrives-despite-exit-gloucester-police-chief/hvH14GgG0dRYTXJOpGEsw
O/story.html.
16
Linda G. Kramer, Berea, Olmsted Township to Host Rally Against Heroin: Community
Voices, CLEVELAND.COM (Sept. 27, 2016), https://www.cleveland.com/berea/index.ssf/2016
/09/berea_olmsted_township_to_host_1.html.
17
Id.
18
Edward Helmore, ‘He’s Trying to Save Lives’: The Ex-Addict Judge on the Frontline
of the Opiate Crisis, GUARDIAN (Aug. 20, 2017), https://www.theguardian.com/usnews/2017/aug/20/opioid-crisis-america-buffalo-new-york-trump-national-emergency.
19
Timothy Williams, This Judge Has a Mission: Keep Defendants Alive, N.Y. TIMES
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is, simply put, to save lives—to allow addicts “to have another sunset,
another time with their family, to see another Christmas.”20 And Hannah
knows all too well the challenges addiction presents: he is seventeen years
in recovery himself from a dependence on marijuana and cocaine that robbed
him of the opportunity to become a Marine Corps officer.21
Recognizing the lethal threat facing the burgeoning number of arrestees
with opioid addiction, other jurisdictions have joined Buffalo. An “Opioid
Intervention Court” has been established in Cumberland County,
Pennsylvania22 and specialized programs for opioid-addicted offenders now
exist in three of New York City’s five boroughs,23 as well as Rensselaer24
and Monroe25 counties, both in upstate New York.
The enthusiasm for establishing opioid courts has not been uniform,
however. A task force studying the issue in Connecticut recommended
against the initiative recently, concluding inter alia that the opioid crisis is
fundamentally “a public health problem.”26 As such, “tethering treatment
too much to the court process may be counterproductive.”27
Issues of race are also concerning in this context. While the opioid
crisis has impacted all groups, whites have been affected most severely.
(Jan. 3, 2018), https://www.nytimes.com/2018/01/03/us/buffalo-heroin-opioid-court.html.
20
Eric Westervelt, To Save Opioid Addicts, This Experimental Court Is Ditching the
Delays, NPR (Oct. 5, 2017), https://www.npr.org/sections/health-shots/2017/10/05/5538307
94/to-save-opioid-addicts-this-experimental-court-is-ditching-the-delays.
21
See Helmore, supra note 18; see also Williams, supra note 19.
22
Opioid Intervention Court, CUMBERLAND COUNTY PA., https://www.ccpa.net/4698/Op
ioid-Intervention-Court (last visited May 10, 2019).
23
Press Release, Eric Gonzalez, Dist. Attorney, Dist. Attorney Kings Cty., Brooklyn
District Attorney Announces Project Brooklyn CLEAR to Offer Treatment for Individuals
Arrested with Small Amount of Narcotics (Mar. 6, 2018), http://www.brooklynda.org/2018/
03/06/brooklyn-district-attorney-announces-project-brooklyn-clear-to-offer-treatment-forindividuals-arrested-with-small-amount-of-narcotics/ (describing Project Collaborative Legal
Engagement Assistance Response (CLEAR)); Press Release, Lawrence K. Marks, Chief
Admin. Judge, N.Y. State Unified Court Sys., New Bronx Drug Courts Aim to Divert Opioid
Drug Offenders at High Risk of Overdose (Jan. 29, 2018), http://ww2.nycourts.gov/sites/defa
ult/files/document/files/2018-05/PR18_01.pdf (describing Overdose Avoidance and
Recovery program); Michael E. McMahon, Staten Island: Heroin and Opioid Crisis,
https://nyshealthfoundation.org/wp-content/uploads/2017/12/michael-mcmahon-slides-pophealth-2017.pdf (last visited May 10, 2019) (describing HOPE program).
24
Kenneth C. Crowe II, Rensselaer County Drug Court Uses Grant to Give Opioid
Addicts New Start, TIMESUNION (May 29, 2018), https://www.timesunion.com/news/article/
Rensselaer-County-Drug-Court-uses-grant-to-give-12949833.php.
25
Kelly Burch, Opioid Court Aims to Prevent Overdose by Offering Treatment, THE FIX
(Dec. 3, 2018), https://www.thefix.com/opioid-court-aims-prevent-overdose-offeringtreatment.
26
STATE OF CONN. JUDICIAL BRANCH, TASK FORCE TO STUDY THE FEASIBILITY OF
ESTABLISHING OPIOID INTERVENTION COURTS 22 (Draft Jan. 1, 2019),
https://www.jud.ct.gov/Committees/Opioid_taskforce/Opioid_TF_Report_112918.pdf.
27
Id.
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Nearly ninety percent of individuals addicted to opioids are white.28
According to the Centers for Disease Control and Prevention, the 2016
opioid-induced mortality rate for whites was forty-one percent higher than
for blacks and sixty-five percent higher than for Hispanics.29 “The drug
overdose epidemic,” the American Council on Science and Health
concludes, “is getting worse . . . and [is] disproportionately affecting
whites.”30 Dr. Andrew Kolodny, Co-Director of Brandeis University’s
Opioid Policy Research Collaborative, commenting on the “overwhelmingly
white” nature of the opioid crisis, opines that racial disparities stem from
doctors’ greater willingness to prescribe powerful pain medication to whites,
thereby fueling their addiction.31 A wealth of data supports this position.32
The foregoing begs the question of whether specialized courts or
programs are appropriate for addressing this particular crisis. Crack cocaine
ravaged urban communities of color in the 1980s and 1990s33 with no
comparable governmental response. There was, of course, no shortage of
legislative activity and political rhetoric surrounding that epidemic; they
focused, however, not on curing addiction, but rather on increasing criminal
sanctions for the possession of a drug whose use was primarily associated
with minority populations.34 For example, the Anti-Drug Abuse Act of 1986
endeavored to combat the crack problem by adopting a 100-to-1 ratio
treating every gram of crack cocaine as the equivalent of 100 grams of white28
See Anjali Om, The Opioid Crisis in Black and White: The Role of Race in Our
Nation’s Recent Drug Epidemic, 40 J. PUB. HEALTH e614, e614 (2018).
29
See NAT’L CTR. FOR INJURY PREVENTION & CONTROL, CTRS. FOR DISEASE CONTROL &
PREVENTION, ANNUAL SURVEILLANCE REPORT OF DRUG-RELATED RISKS AND OUTCOMES 65–
66 (2018), https://www.cdc.gov/drugoverdose/pdf/pubs/2018-cdc-drug-surveillance-report.p
df.
30
Alex Berezow, White Overdose Deaths 50% Higher than Blacks, 167% Higher than
Hispanics,
AM.
COUNCIL
ON
SCI.
&
HEALTH
(Apr.
5,
2018),
https://www.acsh.org/news/2018/04/05/white-overdose-deaths-50-higher-blacks-167higher-hispanics-12804.
31
All Things Considered: Why Is the Opioid Epidemic Overwhelmingly White?, NPR
(Nov. 4, 2017), https://www.npr.org/2017/11/04/562137082/why-is-the-opioid-epidemicoverwhelmingly-white.
32
See, e.g., George Jay Unick et al., Intertwined Epidemics: National Demographic
Trends in Hospitalizations for Heroin- and Opioid-Related Overdoses, 1993–2009, PLOS
ONE, February 2013, at 1.
33
See Jamie Fellner, Race, Drugs, and Law Enforcement in the United States, 20 STAN.
L. & POL’Y REV. 257, 262–65 (2009) (noting the extent to which the proliferation of crack
cocaine blighted low-income, inner-city, minority neighborhoods in the 1980s and 1990s as
drug dealers fought for control over distribution).
34
Legislative and law enforcement efforts coalesced around an urban “underclass”
widely believed to be “dangerous, offensive, and undesirable.” Robert J. Sampson & Janet
L. Lauritsen, Racial and Ethnic Disparities in Crime and Criminal Justice in the United
States, 21 CRIME & JUST. 311, 358 (1997). In African-American neighborhoods in particular,
crack became “a lightning rod for a complicated and deep-rooted set of racial, class, political,
social, and moral dynamics.” Fellner, supra note 33, at 264.
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powder cocaine.35 Mandatory minimum sentence provisions—added by
additional legislation two years later36—exacerbated the distinction between
crack and white powder, prescribing dramatically longer terms of
incarceration for possessing low-levels of crack than far greater quantities of
other drugs, including white powder cocaine.37
This demonization of addiction and its accompanying racial injustice
have fostered widespread criticism leading, in December 2018, to longoverdue criminal justice reform designed to curb at least some of its
excesses.38 Rethinking approaches to drug-related offenses is welcome in
this context; this does not necessarily suggest, however, that specialized
courts are the answer, especially if they disproportionately benefit white
offenders. In addressing the wisdom of opioid courts, this Article is mindful
of their potential challenges to equal justice and wonders if we can minimize
such effects while retaining a focus on the mental health aspects of this
national crisis.
II. THE DRUG COURT MODEL
In evaluating the need for opioid courts, we must start with drug courts,
which presently manage opioid-addicted offenders. First established in
Florida in 1989,39 drug courts are specialized programs that provide an
alternative to the traditional criminal courts for certain individuals—
typically first-time, nonviolent offenders who abuse drugs and/or alcohol.40
35

See Kimbrough v. United States, 552 U.S. 85, 96 (2007).
See The Anti-Drug Abuse Act of 1988, Pub. L. No. 100-690, 102 Stat. 4181 (1988).
37
U.S. SENTENCING COMM’N, REPORT TO THE CONGRESS: COCAINE AND FEDERAL
SENTENCING POLICY 11 (2002), https://www.ussc.gov/sites/default/files/pdf/news/congressio
nal-testimony-and-reports/drug-topics/200205-rtc-cocaine-sentencing policy/200205Cocain
e_and_Federal_Sentencing_Policy.pdf; see also Hilary E. LaBar, Note, The Fair Sentencing
Act Isn’t All It’s “Cracked” Up to Be: How Recent Congressional Action on Federal Crack
Cocaine Sentencing Schemes Failed to End the Disparity Between Crack and Powder
Cocaine Offenses, 64 SYRACUSE L. REV. 313, 324–25 (2014).
38
On December 21, 2018, President Trump signed the “First Step Act” into law. See
Jamiles Lartey, Trump Signs Bipartisan Criminal Justice Overhaul First Step Act into Law,
THE GUARDIAN (Dec. 21, 2018), https://www.theguardian.com/us-news/2018/dec/21/trumpprison-reform-first-step-act-signed-law. Among its various criminal justice reforms, the First
Step Act relaxes mandatory-minimum sentences on a variety of drug charges; increases
judges’ discretionary authority to reduce the sentences of offenders convicted of nonviolent
drug crimes; and, importantly, redresses the aforementioned inequities in sentencing rules for
crack and powder cocaine offenses, a distinction that has disproportionately affected African
Americans. See Editorial Board, The First Step Act Will Offer a Fairer Deal to Prison
Inmates, WASH. POST: THE POST’S VIEW (Dec. 19, 2018), https://www.washingtonpost.com
/opinions/the-first-step-act-will-offer-a-fairer-deal-to-prison-inmates/2018/12/19/06d9e6aa03c8-11e9-b6a9-0aa5c2fcc9e4_story.html?noredirect=on&utm_term=.40bc3a31a416.
39
Drug Courts, FLA. CTS. (last visited May 10, 2019), https://www.flcourts.org/Resourc
es-Services/Court-Improvement/Problem-Solving-Courts/Drug-Courts.
40
See LISA N. SACCO, CONG. RESEARCH SERV., R44467, FEDERAL SUPPORT FOR DRUG
36
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There are currently more than 3,000 drug courts in the United States.41
Approximately half are adult-treatment drug courts42 whose primary goal is
to reduce participants’ “propensity to commit further crimes by treating their
addictive disease.”43
While there is a significant amount of procedural variation across
jurisdictions, drug courts divide essentially into two major models: “preplea” and “post-plea.” In the “pre-plea” model, defendants who meet
eligibility requirements are diverted into the drug court system prior to
pleading to a charge. They are not required to plead guilty, and those who
complete the drug court program are not prosecuted further. Noncompletion of the program, however, typically leads to prosecution.44 In the
“post-plea” model, defendants must plead guilty to criminal charges, but
their sentences are deferred or suspended while they participate in the drug
court program. Successful completion of the program results in a waived
sentence and sometimes an expungement of the offense. However, in cases
where individuals fail to meet the requirements of the drug court (such as a
habitual recurrence of drug use), they will be returned to the traditional
criminal court to face sentencing on their guilty plea.45
Whether a pre- or post-plea model, drug courts share a set of unifying
principles called “key components.”46 Viewed collectively, these principles
describe a non-adversarial partnership among courts, public agencies, and
community-based organizations to provide education and a continuum of
treatment and rehabilitation services to addicted offenders. Participants are
typically subjected to a multiphase treatment approach that proceeds from
stabilization to intensive treatment and, ultimately, transition.47 The
stabilization phase provides an initial assessment, as well as a period of
COURTS: IN BRIEF 1 (2018), https://fas.org/sgp/crs/misc/R44467.pdf.
41
Drug Courts, NAT’L INST. JUST. (last updated Aug. 23, 2018), http://www.nij.gov/topi
cs/courts/drug-courts/.
42
U.S. DEPT. OF JUSTICE, DRUG COURTS 1 (2018), https://www.ncjrs.gov/pdffiles1/nij/23
8527.pdf.
43
Peggy Fulton Hora & Theodore Stalcup, Drug Treatment Courts in the Twenty-First
Century: The Evolution of the Revolution in Problem-Solving Courts, 42 GA. L. REV 717, 726
(2008) (footnote omitted). As Judge Hora, who presided over a drug treatment court for years,
noted, “merely incarcerating substance abusers or placing them on probation without
treatment fails to treat the disease and invites the inevitability of recidivism.” Id. at 724
(footnote omitted).
44
RYAN S. KING & JILL PASQUARELLA, THE SENTENCING PROJECT, DRUG COURTS: A
REVIEW OF THE EVIDENCE 3 (2009),
http://www.sentencingproject.org/wpcontent/uploads/2016/01/Drug-Courts-A-Review-of-the-Evidence.pdf.
45
Id.
46
DRUG COURT STANDARDS COMM., NAT’L ASS’N OF DRUG COURT PROF’LS, DEFINING
DRUG COURTS: THE KEY COMPONENTS (U.S. DEP’T OF JUSTICE, DRUG COURTS RES. SER. NO.
205621, 2004), https://www.ncjrs.gov/pdffiles1/bja/205621.pdf.
47
SACCO, supra note 40, at 4.

CORNWELL (DO NOT DELETE)

1004

5/24/2019 12:42 PM

SETON HALL LAW REVIEW

[Vol. 49:997

detoxification and education. The intensive treatment that follows typically
involves counseling and other therapy. The transition phase focuses on
reintegration in a variety of contexts, such as social integration, employment,
education, and housing.48
Frequent monitoring and evaluation are key parts of the strategic plan.49
These functions are carried out by a team of interested parties, which
typically includes the prosecutor, defense counsel, probation officers,
substance abuse professionals, and community corrections personnel.50 The
judge essentially functions as the team leader, coordinating and integrating
all aspects of the defendant’s journey as he progresses from initial
detoxification to aftercare. Thus, the relationship between the judge and the
offender is the primary focus of drug court proceedings,51 as he or she strives
to create a personal and therapeutic working relationship with the offender.52
To no small degree, the offender’s success vel non in completing the program
revolves around the strength and vitality of this relationship;53 the realization
of this objective requires, in turn, the investment of significant judicial
resources involving both “passion and time.”54
Capturing the variety and complexity of drug court judges’
participation, Joshua Matt identified five interdependent roles they play in
the process, based on his interviews with two drug court judges in
Massachusetts: fact-gatherer, treatment counselor, problem-solver,
collaborator, and administrative taskmaster.55 Viewed collectively, these
functions underscore the breadth of the demands placed on drug court judges
in ways that differ from expectations attendant to ordinary criminal
proceedings. For example, to realize the underlying goal of restoring an
offender’s sobriety, the judge must first gain an in-depth knowledge of a
defendant’s personal situation with respect to drug use, family
48

Id.
See DRUG COURT STANDARDS COMM., supra note 46, at 17–20.
50
Hora & Stalcup, supra note 43, at 726; see also Gregory Baker, Do You Hear the
Knocking at the Door? A “Therapeutic” Approach to Enriching Clinical Legal Education
Comes Calling, 28 WHITTIER L. REV. 379, 400 (2006).
51
See Eric J. Miller, Embracing Addiction: Drug Courts and the False Promise of
Judicial Interventionism, 65 OHIO ST. L.J. 1497, 1493 (2004).
52
See Pamela L. Simmons, Comment, Solving the Nation’s Drug Problem: Drug Courts
Signal a Move Toward Therapeutic Jurisprudence, 35 GONZ. L. REV. 237, 259 (1999).
53
In one study, researchers found that seventy-three percent of successful drug court
graduates believed that they would not have been able to complete the program if they had
appeared before a different judge. Scott R. Senjo & Leslie A. Leip, Testing Therapeutic
Jurisprudence Theory: An Empirical Assessment of the Drug Court Process, W.
CRIMINOLOGY REV., January 2001, at 1.
54
Kevin S. Burke, Just What Made Drug Courts Successful?, 36 NEW ENG. J. ON CRIM.
& CIV. CONFINEMENT 39, 45 (2010).
55
Joshua Matt, Jurisprudence and Judicial Roles in Massachusetts Drug Courts, 30 NEW
ENG. J. ON CRIM. & CIV. CONFINEMENT 151, 165–71 (2004).
49
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circumstances, housing, and employment history. This informs the
strategies that she or he may subsequently use to identify interventions in the
not-uncommon event of relapse.
Such non-compliance presents a particular challenge for the drug court
judge. While success relies on the creation of a non-adversarial relationship
between the court and the offender, accountability is a critical programmatic
component.56 Failure to follow the rules may thus result in short terms of
incarceration, sometimes called “smart punishment.”57 This sanction, while
presumptively necessary, has led some to criticize drug courts as
insufficiently empathic and overly incapacitative in effect.58 The Drug
Policy Alliance59 contends, in this regard, that drug courts are fundamentally
incompatible with the disease model of addiction under which they purport
to operate. Whereas the latter teaches that addicts “cannot control their use
while others can,”60 drug courts paradoxically presume that addicts are
rational actors who can be held criminally responsible for substance abuse.61
By blending the disease and rational actor models, drug courts “cannot
adhere to both approaches and faithfully embody either one.”62
However imperfect drug courts may be, studies have found that they
have been effective in reducing recidivism and lowering the costs associated
with managing addicted offenders.63 For example, in a decade-long
evaluation of twenty-two drug court programs, the National Institute of
Justice rated twenty as either “promising” or “effective,” particularly
emphasizing their positive results in reducing recidivism.64
West
Huddleston and Douglas Marlowe are even more sanguine, commenting in
56

Id. at 170.
See Jeffrey S. Trauber, Drug Courts: A Judicial Manual, CJER J., Summer 1999, at 1,
9–10 (discussing “smart punishment”).
58
See Miller, supra note 51, at 1575.
59
The Drug Policy Alliance is a non-profit organization based in New York City whose
“mission is to advance those policies and attitudes that best reduce the harms of both drug use
and drug prohibition, and to promote the sovereignty of individuals over their minds and
bodies.” About Us, DRUG POL’Y ALLIANCE, http://www.drugpolicy.org/about-us (last visited
May 10, 2019).
60
Addiction as a Disease, CTR. ON ADDICTION, https://www.centeronaddiction.org/whataddiction/addiction-disease (last updated Apr. 14, 2017).
61
See DRUG POLICY ALL., DRUG COURTS ARE NOT THE ANSWER: TOWARD A HEALTHCENTERED APPROACH TO DRUG USE 16 (2011), https://www.drugpolicy.org/sites/default/files
/Drug%20Courts%20Are%20Not%20the%20Answer_Final2.pdf.
62
Id.
63
See generally Do Drug Courts Work? Findings from Drug Court Research, NAT’L
INST. JUST., http://www.nij.gov/topics/courts/drug-courts/Pages/work.aspx (last updated May
1, 2018).
64
See Nat’l Inst. of Justice, Specialized & Problem Solving Courts: Drug Courts,
CRIMESOLUTIONS.GOV, https://www.crimesolutions.gov/TopicDetails.aspx?ID=238 (last
visited May 10, 2019).
57
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2011 that the scientific literature establishes conclusively that adult drug
courts reduce crime and save money, while juvenile drug courts reduce both
substance abuse and delinquency.65 Such salutary findings led Lisa Sacco, a
prominent federal drug and crime policy analyst, to ask Congress to consider
increasing funding for drug court programs to combat the opioid epidemic.66
To be clear, drug courts presently serve opioid-addicted offenders. In
fact, individuals addicted to opioids represent an ever-increasing percentage
of drug court participants. According to a nationwide survey published in
2013, upwards of ninety-eight percent of drug courts reported that their
programs included at least some opioid-dependent individuals, with almost
half estimating that more than twenty percent of participants were opioiddependent.67 These increases are not surprising. From 2005 to 2008, rural
drug courts saw opioids increase from six to nineteen percent as the drug of
choice for their participants68 and, as discussed earlier,69 the opioid crisis has
further metastasized across the country since then.
Folding opioid abusers into the existing drug court model is not without
its problems, however. If Congress is to invest large sums of taxpayer money
in drug court expansion to combat opioid addiction, it must recognize these
roadblocks and endeavor to overcome them. The next section addresses this
challenge.
III. USING DRUG COURTS TO MANAGE OPIOID-ADDICTED OFFENDERS
Opioid abusers, like other offenders referred to drug courts, need a
holistic treatment plan anchored by a readily-available judge who closely
monitors all aspects of the offender’s progress. In that sense, drug courts
seem a good fit for individuals addicted to opioids. Unfortunately, when it
comes to treatment, this compatibility erodes. Most drug courts do not
provide medication-assisted treatment (MAT) to participants; instead
abstinence is promoted primarily through twelve-step, “mutual-support

65

WEST HUDDLESTON & DOUGLAS B. MARLOWE, NAT’L DRUG COURT INST., PAINTING
THE CURRENT PICTURE: A NATIONAL REPORT ON DRUG COURTS AND OTHER PROBLEMSOLVING
COURT
PROGRAMS
IN
THE
UNITED
STATES
9–12
(2011),

http://www.ndci.org/sites/default/files/nadcp/PCP%20Report%20FINAL.PDF.
66
SACCO, supra note 40, at 10.
67
Harlan Matusow et al., Medication Assisted Treatment in US Drug Courts: Results
from a Nationwide Survey of Availability, Barriers and Attitudes, 44 J. SUBSTANCE ABUSE
TREATMENT 473, 475 (2013).
68
See C. WEST HUDDLESTON, III ET. AL., NAT’L DRUG COURT INST., PAINTING THE
CURRENT PICTURE: A NATIONAL REPORT CARD ON DRUG COURTS AND OTHER PROBLEMSOLVING
COURT
PROGRAMS
IN
THE
UNITED
STATES
12
(2008),
http://faculty.uml.edu/jbyrne/44.203/DrugCourtsReport.pdf; HUDDLESTON & MARLOWE,
supra note 65, at 31.
69
See supra text accompanying notes 1–9.
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groups” like Alcoholics Anonymous and Narcotics Anonymous.70
According to recent data, almost half of all drug courts do not offer
pharmacological interventions.71 One recent multi-site survey reported even
less availability, estimating that fewer than twenty-five percent offered
MAT.72
While the abstinence-only model may be appropriate for those
suffering from substance abuse disorders like alcoholism, it does not reflect
best practices with respect to opioid addiction. Both the U.S. Department of
Health and Human Services73 and the World Health Organization74 have
found MAT to be indispensable in managing opiate dependence. This does
not mean that behavioral therapy is unimportant; rather, for most, a
combination of medication-based and “talk” therapy is optimal to account
for differences in patient response in the hope of achieving a sort of synergy
between the two approaches.75
There are three medications used in the treatment of opioid addiction:
methadone, buprenorphine (commonly known by its brand name,
Suboxone), and Vivitrol (an extended-release form of naltrexone).76
70

See Sara Gordon, The Use and Abuse of Mutual-Support Program in Drug Courts,
2017 U. ILL. L. REV. 1503, 1540 (2017).
71
See BENJAMIN R. NORDSTROM & DOUGLAS B. MARLOWE, NAT’L DRUG COURT INST.,
DRUG COURT PRACTITIONER FACT SHEET: MEDICATION-ASSISTED TREATMENT FOR OPIOID
USE
DISORDERS
IN
DRUG
COURTS
(2016),
http://www.ndci.org/wpcontent/uploads/2018/09/mat_fact_sheet-1.pdf (only fifty-six percent of drug courts offer any
MAT, with fifty percent allowing only one of the three FDA-approved medication to fight
opioid addiction); see also Stephen Hunter et al., New Jersey’s Drug Courts: A Fundamental
Shift from the War on Drugs to a Public Health Approach for Drug Addiction and DrugRelated Crime, 64 RUTGERS L. REV. 795 (2012) (most New Jersey drug courts do not provide
MAT and those that do require participants to wean off the medication to successfully
complete drug court).
72
3 SHELLI B. ROSSMAN ET AL., URBAN INST. JUSTICE POLICY CTR., THE MULTI-SITE
ADULT DRUG COURT EVALUATION: THE DRUG COURT EXPERIENCE 51 (2011) (twenty-three
percent of drug courts provide “pharmacological interventions”).
73
See OFFICE OF THE ASSISTANT SEC’Y FOR PLANNING & EVALUATION, U.S. DEP’T OF
HEALTH & HUMAN SERVS., EXECUTIVE SUMMARY: OPIOID ABUSE IN THE U.S. AND HHS
ACTIONS TO ADDRESS OPIOID-DRUG RELATED OVERDOSES AND DEATHS (2015),
http://aspe.hhs.gov/sp/reports/2015/OpioidInitiative/es_OpioidInitiative.pdf.
74
See WORLD HEALTH ORG., WHO MODEL LIST OF ESSENTIAL MEDICINES 1, 32 (18th
ed. 2013), http://apps.who.int/iris/bitstream/10665/93142/1/EML_18_eng.pdf?ua=1; see also
ANDREJ KASTELIC, JÖRG PONT & HEINO STÖVER, OPIOID SUBSTITUTION TREATMENT IN
CUSTODIAL SETTINGS: A PRACTICAL GUIDE (Fabienne Hariga et al. eds., 2008),
http://www.unodc.org/documents/hiv-aids/OST_in_Custodial_Settings.pdf.
75
See NAT’L CTR. ON ADDICTION & SUBSTANCE ABUSE AT COLUMBIA UNIVERSITY,
ADDICTION MEDICINE: CLOSING THE GAP BETWEEN SCIENCE AND PRACTICE, at i (2012); Albert
J. Arias & Henry R. Kranzler, Treatment of Co-Occurring Alcohol and Other Drug Use
Disorders, 31 ALCOHOL RES. & HEALTH 155, 156 (2008).
76
Barbara Andraka-Christou, What Is “Treatment” for Opioid Addiction in ProblemSolving Courts? A Study of 20 Indiana Drug and Veterans Courts, 13 STAN. J. C.R. & C.L.
189, 219 (2017).

CORNWELL (DO NOT DELETE)

1008

5/24/2019 12:42 PM

SETON HALL LAW REVIEW

[Vol. 49:997

Methadone is a synthetic opioid that acts on opioid receptors in the brain.77
Buprenorphine is a semi-synthetic opioid that binds to the same receptors as
methadone but activates them less strongly.78 Both medications work by
maintaining a level of opioid sufficient to prevent withdrawal while
alleviating drug cravings.
Vivitrol, approved by the U.S. Food and Drug Administration in 2010
for the treatment of opioid addiction, is the newest of the three
interventions.79
Unlike methadone and buprenorphine, which are
administered orally, Vivitrol is injected once a month intramuscularly80 and
directly blocks opioids from binding to receptors in the brain.81 As such, it
prevents addicts from feeling the euphoria that otherwise results from taking
heroin or other opioids.82 An opioid antagonist, Vivitrol will cause
withdrawal if individuals have any opiates in their system when taking it;
therefore, individuals must have fully detoxified before the first injection.83
As mentioned earlier, drug courts have traditionally required total
abstinence from all participants. In her 2015-2016 survey of twenty drug
and veterans courts in Indiana,84 Barbara Andraka-Christou provides insight
into current judicial attitudes towards medication-assisted treatment for
opioid addiction. On an encouraging note, she found that the judges
commonly allow defendants to enter a drug court program while on MAT.85
Unfortunately, authorization to remain on MAT going forward varied
significantly, and often depended on the particular medication used. For
example, there was a marked dislike for, and suspicion of, methadone—one
judge commenting that it was “a hideous, awful thing.”86 Unsurprisingly,
77
How Do Medications to Treat Opioid Use Disorder Work?, NAT’L INST. ON DRUG
ABUSE, https://www.drugabuse.gov/publications/research-reports/medications-to-treat-opioi
d-addiction/how-do-medications-to-treat-opioid-addiction-work (last visited May 10, 2019).
78
Id.
79
See FDA Approves Vivitrol for Opiate Addiction Treatment, CRC HEALTH,
https://www.crchealth.com/find-a-treatment-center/opiate-addiction-treatment-centers/addit
ional-resources/fda-approves-vivitrol-opiate-addiction-treatment/ (last visited May 10, 2019).
80
Id.
81
Overview of Vivitrol (Naltrexone), AM. ADDICTION CTR., https://americanaddictioncen
ters.org/addiction-medications/vivitrol (last visited May 10, 2019).
82
See Rachel Dissell, Vivitrol, Suboxone and Methadone: What We Know About
Medicines Used to Treat Opioid Addiction, CLEVELAND.COM (Apr. 30, 2017),
https://www.cleveland.com/metro/index.sf/2017/04/vivitrol_suboxone_and_methadon.html.
83
What Is Vivitrol?, CTR. FOR BEHAV. HEALTH, http://centerforbehavioralhealth.com/
treatment-method-vivitrol/ (last visited May 10, 2019).
84
Indiana’s veterans and drug courts are similar in operation, except that the former is
limited to former members of the armed services and includes extensive mental health
treatment for co-occurring conditions like post-traumatic stress disorder. Andraka-Christou,
supra note 76, at 193.
85
Id. at 227.
86
Id. at 230. Judges’ principal complaints revolved around the drug’s addictive nature
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this viscerally negative perception has eroded judges’ willingness to allow
defendants to continue using methadone, or to start it, while in drug court.87
Attitudes toward buprenorphine and Vivitrol are decidedly more
positive, especially the latter. Andraka-Christou found that, with respect to
Vivitrol, judges who were aware of it were in favor of it, and those who were
unfamiliar with it wanted to learn more based on positive word of mouth.88
The greater enthusiasm surrounding Vivitrol is not surprising since, unlike
the other MAT options, it is not an opioid and thus does not challenge
abstinence principles to the same degree. As a partial opioid agonist,
buprenorphine receives a warmer reception than methadone, but judges
nonetheless remain wary. For example, while sixteen of the twenty courts
surveyed allowed buprenorphine treatment during the program, seven
required participants to wean off the medication before graduating.89
Requiring individuals who have been successfully maintained on
methadone or buprenorphine to discontinue MAT to graduate from a drug
court program fundamentally misconstrues the nature of these medications
and their effect on those who use them. While methadone and buprenorphine
create physical dependence, such dependence is markedly distinct from
addiction. Addiction is characterized by “compulsive drug seeking” and
“continued use despite harmful consequences.”90 This loss of control stands
in stark contrast to those stabilized on an appropriate dose of methadone or
buprenorphine who, by eliminating cravings, avoid self-destructive
behaviors and their harmful consequences.91 These medications allow them
to lead productive lives focused on work, family, and wellness.92 As one
user noted: “With Suboxone, I take my pill in the morning and then go about
my day.”93
and overdose potential, their belief that it did not promote abstinence, and concerns about the
mismanagement of methadone clinics. Id.
87
See id. at 228.
88
Id. at 235.
89
Id. at 232.
90
NAT’L INST. ON DRUG ABUSE, U.S. DEP’T OF HEALTH & HUMAN SERVS., MEDIA GUIDE:
THE SCIENCE OF DRUG USE AND ADDICTION: THE BASICS 1 (rev. ed. 2018),
https://d14rmgtrwzf5a.cloudfront.net/sites/default/files/media_guide.pdf.
91
See SUBSTANCE ABUSE & MENTAL HEALTH SERVS. ADMIN., U.S. DEP’T OF HEALTH
AND HUMAN SERVS., THE FACTS ABOUT BUPRENORPHINE FOR TREATMENT OF OPIATE
ADDICTION 2–3 (2015), https://store.samhsa.gov/product/The-Facts-about-Buprenorphinefor-Treatment-of-Opioid-Addiction/SMA15-4442; Robyn Oster, Understanding the
Difference Between Physical Dependence and Addiction, CTR. ON ADDICTION: THE BUZZ
(Nov. 14, 2017), https://www.centeronaddiction.org/the-buzz-blog/understanding-difference
-between-physical-dependence-and-addiction.
92
See id.
93
Sally Friedman & Melissa Trent, Defense Lawyers and the Opioid Epidemic:
Advocating for Addiction Medication, THE CHAMPION, Aug. 2018, at 20, 25,
https://lac.org/wp-content/uploads/2018/10/Defense-Lawyers-Opiod-Epidemic-Champion-
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By contrast, the abrupt withdrawal of maintenance medications risks
grave consequences. Consider, for example, Robert Lepolszki’s tragic
story.94 Addicted to heroin, he seemed to turn a corner after entering a
methadone treatment program. For the first time in years, he was faithfully
submitting to drug testing and holding down a job. Sadly, in the midst of
this recovery, Robert was arrested for the unlawful sale of Xanax, a crime he
had committed more than a year earlier before he had begun methadone
therapy. His case was assigned to the county drug court, where the judge
required him to stop taking the medication to avoid jail time, notwithstanding
its positive effects. He quickly spiraled downward, descended into drug use
once again and ultimately overdosed at the age of twenty-eight.
As Lepolszki’s story underscores, individuals struggling with opioid
addiction often need MAT for extended periods of time to address their
condition95 and, if cessation of treatment is appropriate, it requires close
medical supervision during the tapering process to avoid dangerous medical
complications, including life-threatening relapses.96 This reality highlights
how critical it is that drug courts embrace MAT if they are going to
successfully manage the large number of opioid abusers flooding the
criminal justice system. And this acceptance must be full-throated,
encompassing not only the initiation of methadone, buprenorphine or
Vivitrol, but its continuation, as needed, throughout the program and after
graduation.
The looming question is whether drug court judges will be willing to
make this transition. The National Association of Drug Court Professionals
(NADCP) has increasingly advocated for MAT, promulgating best practices
standards in recent years that direct its judges “to offer MAT when
prescribed and monitored by a physician with expertise in . . . addiction

Aug-2018.pdf.
94
The facts that follow are reported in Maia Szalavitz, How America Overdosed on Drug
Courts, PACIFIC STANDARD, https://psmag.com/news/how-america-overdosed-on-drugcourts (last updated May 3, 2017).
95
As the Center for Court Innovation has noted, the duration of MAT varies significantly
from patient to patient and may be indefinite for some. SALLY FRIEDMAN & KATE WAGNERGOLDSTEIN, CTR. FOR CT. INNOVATION, MEDICATION-ASSISTED TREATMENT IN DRUG COURTS:
RECOMMENDED
STRATEGIES
10
(2015),
https://lac.org/resources/substance-useresources/medication-assisted-treatment-resources/medication-assisted-treatment-in-drugcourts-recommended-strategies/. For those on methadone, like Robert Lepolszki, twelve
months is the minimum. NAT’L INST. ON DRUG ABUSE, U.S. DEP’T OF HEALTH & HUMAN
SERVS., PRINCIPLES OF DRUG ADDICTION TREATMENT: A RESEARCH-BASED GUIDE (3d ed.
1999), http://www.drugabuse.gov/sites/default/files/podat_1.pdf.
96
See OFFICE OF NAT’L DRUG CONTROL POLICY, EXEC. OFFICE OF THE PRESIDENT,
MEDICATION-ASSISTED
TREATMENT
FOR
OPIOID
ADDICTION
3–4
(2012),
https://obamawhitehouse.archives.gov/sites/default/files/ondcp/Fact_Sheets/medication_assi
sted_treatment_9-21-2012.pdf.
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medicine.”97 Policy advocates recognize, at the same time, that the
recommendation is aspirational, noting that “[d]espite best efforts at
education and outreach, some drug courts may continue to deny MAT as a
matter of policy.”98 During this period, he addresses all aspects of the
participant’s recovery, from treatment to employment to struggles in a
person’s personal or family life. “I’m going to be your new best friend,”
Hannah tells them. “So I’m going to start calling you by your first name
from now on.”99 While drug court judges meet frequently with other
offenders, the interaction is not nearly as frequent or interpersonally
intense.100
IV. DRUG COURTS AND RACIAL JUSTICE
Drug courts have been criticized for disparities between whites and
participants of color, especially African-Americans. Some have argued that
drug courts have a “net-widening” effect by encouraging law enforcement
and other institutional actors to prosecute even minor drug offenses more
aggressively, thereby sweeping more racial minorities into the criminal
justice system and serving as a potential gateway to deeper criminal
involvement and punishment.101 Commentators also point to troubling
statistics indicating that racial minorities are significantly less likely to be
enrolled in drug courts in the first place, even after controlling for criminal
history.102 There is also evidence that, once enrolled, African Americans are
less likely to graduate from drug courts than whites.103
97

Douglas B. Marlowe et al., Increasing Access to Medication-assisted Treatment for
Opioid Addiction in Drug Courts and Correctional Facilities and Working Effectively with
Family Courts and Child Protective Services 6 (Am. Ass’n for the Treatment of Opioid
Dependence, Inc., Whitepaper No. 3, 2016), http://www.aatod.org/policies/mat-hub-settingwhitepapers/number-3/.
98
Id. at 8.
99
Williams, supra note 19.
100
See, e.g., Frederick G. Rockwell III, The Chesterfield/Colonial Heights Drug Court:
A Partnership Between the Criminal Justice System and the Treatment Community, 43 U.
RICH. L. REV. 5, 10 (2008) (offenders meet weekly with drug court judge who enforces and
rewards client participation and compliance).
101
See, e.g., Joel Gross, The Effects of Net-Widening on Minority and Indigent Drug
Offenders: A Critique of Drug Courts, 10 U. MD. L.J. RACE RELIGION GENDER & CLASS 161
(2010); Robert V. Wolf, Race, Bias, and Problem-Solving Courts, 21 NAT’L BLACK L.J. 27
(2009).
102
See JUSTICE POLICY INST., ADDICTED TO COURTS: HOW A GROWING DEPENDENCE ON
DRUG
COURTS
IMPACTS
PEOPLE
AND
COMMUNITIES
21
(2011),
http://www.justicepolicy.org/uploads/justicepolicy/documents/addicted_to_courts_final.pdf;
Nancy Nicosia et al., Disparities in Criminal Court Referrals to Drug Treatment and Prison
for Minority Men, 103 AM. J. PUB. HEALTH e77, e79–e80 (2013).
103
See, e.g., Anne Dannerbeck et al., Understanding and Responding to Racial
Differences in Drug Court Outcomes, 5 J. ETHNICITY SUBSTANCE ABUSE 1 (2008); Jerome
McKean & Kiesha Warren-Gordon, Racial Differences in Graduation Rates from Adult Drug
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That said, the extent to which race impacts drug court access and
outcomes has been far from clear. For example, while a number of studies
reported significant racial disparities in graduation rates, others did not.104 In
light of the uncertainty surrounding this important issue, the Board of
Directors of the National Association of Drug Court Professionals (NADCP)
passed a unanimous resolution in 2010 that directed drug courts to determine
the extent to which racial disparities existed and how to redress any problems
they unearthed.105
In 2018, the NADCP released the first volume of the Journal for
Advancing Justice, a publication funded by the U.S Department of Justice
that is designed to provide “a forum to share evidence-based and promising
practices at the intersection of the justice and public health systems.”106 The
journal’s inaugural issue responds to the Board of Directors’ 2010 resolution
by providing “cutting-edge findings from the largest multisite studies
conducted to date on racial, ethnic, and gender disparities in treatment
courts.”107 In the two studies that analyzed graduation rates,108 both reported
significantly less success for non-Caucasian participants. In one, the
disparity was significant only for African Americans; Hispanics/Latinos

Treatment Courts, 9 J. ETHNICITY CRIM. JUST. 41 (2011); Michael M. O’Hear, Rethinking
Drug Courts: Restorative Justice as a Response to Racial Injustice, 20 STAN. L. & POL’Y REV.
463, 484 (2009) (African Americans “are underrepresented, sometimes quite dramatically,
among program graduates”).
104
See, e.g., Kristen E. DeVall & Christina L. Lanier, Successful Completion: An
Examination of Factors Influencing Drug Court Completion for White and Non-White Male
Participants, 47 SUBSTANCE USE & MISUSE 1106 (2012) (comparing eleven studies, seven of
which found racial inequities). Inconsistency in results was attributable, at least in part, to
various anomalies that exist across studies, including: the grouping of racial minorities into a
single non-White category; selecting individual drug courts or programs for analysis based on
convenience, such as geography and data availability; and disregarding differences in
treatment methods across drug courts. See Ben Gilbertson, Finding Its Place: The Effect of
Race on Drug Court Outcomes, THESES & DISSERTATIONS, May 2011, at 2–3,
https://dc.uwm.edu/cgi/viewcontent.cgi?article=1107&context=etd.
105
Douglas B. Marlowe, Achieving Racial and Ethnic Fairness in Drug Courts, 49 CT.
REV. 40, 40 (2013), http://aja.ncsc.dni.us/publications/courtrv/cr49-1/CR49-1Marlowe.pdf.
106
Identifying and Rectifying Racial, Ethnic, and Gender Disparities in Treatment
Courts, 1 J. ADVANCING JUST. iv, iv (2018), http://advancejustice.org/wpcontent/uploads/2018/06/AJ-Journal.pdf.
107
Id. at 1–2.
108
One of the studies included all court programs that “stem from the drug court model”:
adult drug treatment courts, reentry courts, family drug treatment courts, juvenile drug
treatment courts, and mental health courts. Timothy Ho et al., Racial and Gender Disparities
in Treatment Courts: Do They Exist and Is There Anything We Can Do to Change Them?, 1
J. ADVANCING JUST. 5, 7 n.1 (2018). The other was limited to drug court participants. See
Lisa M. Shannon et al., Examining Racial Disparities in Program Completion and PostProgram Recidivism Rates: Comparing Caucasian and Non-Caucasian Treatment Court
Participants, 1 J. ADVANCING JUST. 63, 67 (2018) (findings based on 534 Kentucky drug court
participants).
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graduated at a rate roughly equivalent to non-Hispanic Whites.109 The other,
which found a 51 percent disparity,110 lumped all “non-Caucasians” into one
category; African Americans accounted, however, for 87 percent of that
group.111 These results are consistent with some earlier studies, discussed
above.112 Interestingly, the study conducted by Timothy Ho and his
colleagues found that the proportion of African Americans in treatment
courts was commensurate with that of the local probation population;
disparities in comparison to Whites existed in only the graduation rate, not
access in the first instance to drug court programs.113 This contradicts
assertions made in some earlier studies and questions the extent to which
drug courts have a “net-widening” effect, as some have suggested.114 In
addition, while the second study, conducted by Lisa Shannon and her
colleagues, reported problematic graduation rates for African Americans,
their study also found that racial disparities disappeared when controlling for
five variables: marijuana as the drug of choice; attendance at a greater
number of detoxification programs in the past year; cocaine use in the thirty
days before assessment for treatment; misdemeanor conviction; and current
probationary or parole status.115
Other studies have likewise posited that disparities in drug court
graduation rates may be attributable to various socio-demographic factors
rather than race per se. For example, Daniel Howard has argued that race is
a proxy for conditions that permeate disadvantaged neighborhoods and drive
down completion rates, including: poverty, unemployment, rampant crime,
and inadequate social services.116 Other researchers agree, and point to
additional factors—such as housing insecurity and education—that
undermine minority participants’ chances for success.117
109

Ho et al., supra note 108, at 6, 23.
Shannon et al., supra note 108, at 63.
111
Id. at 67.
112
See supra text accompanying note 104.
113
Ho et al., supra note 108, at 14–17.
114
See supra text accompanying note 101.
115
Shannon et al., supra note 108, at 71.
116
Daniel Howard, Race, Neighborhood, and Drug Court Graduation, 33 JUST. Q. 159,
161 (2014).
117
See, e.g., Michael W. Finigan, Research Update: Understanding Racial Disparities in
Drug Courts, 6 DRUG CT. REV. 135, 138 (2009) (employment status upon entry,
socioeconomic status, cocaine as primary drug of choice), https://www.ndci.org/wpcontent/uploads/DCRVolume6_Issue2.pdf; Lisa M. Shannon et al., Examining Individual
Factors and During-Program Performance to Understand Drug Court Completion, 55 J.
OFFENDER REHABILITATION 271, 271 (2016) (marital status, employment, and education);
Barbara Smith, Completion Rates: An Analysis of Factors Related to Drug Court Program
Completion, COGENT SOC. SCI., Mar. 2017, at 5 (employment and marital status),
https://www.tandfonline.com/doi/abs/10.1080/23311886.2017.1304500; Dannerbeck et al.,
supra note 103, at 6 (prior incarceration, employment, living arrangements, socioeconomic
110
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What emerges from the foregoing is an imperfect picture of a racial
equity problem whose parameters are somewhat uncertain. Fortunately,
current research has identified strategies that drug court judges and those
who work with them can implement to alleviate racial disparities by
improving the graduation rate of minority participants, especially African
Americans. The Journal for Advancing Justice has included these advances,
highlighting “culturally proficient interventions” that drug courts can
employ to “blunt the piercing impact of racial discrimination and implicit
cultural biases.”118
Among the most promising initiatives is Habilitation Empowerment
Accountability Therapy (HEAT), a “culturally proficient, strength-based,
and trauma-informed group counseling intervention” piloted with African
American men aged eighteen to twenty-nine, a group at heightened risk for
non-completion of drug court programs.119 Participants followed a ninemonth curriculum divided into three parts focusing respectively on the self,
the family, and the community. The section on the self endeavored to erode
negative images attributed to Black men, examining inter alia how the
prevalence in hip-hop culture of themes of misogyny, profanity, and
homophobia “negatively shape society’s perceptions of African American
men and their own self-perceptions.”120 The section on the family focused
on the historical traumas inflicted on African American men, such as
enforced separations during slavery, that have contributed to an
intergenerational cycle of family dysfunction based on paternal absence,
intimate partner violence and child neglect.121 Participants were encouraged
to reflect on these issues and devise strategies to overcome these destructive
patterns in the future.122 Finally, the community-based curriculum addressed
the panoply of challenges confronting African American neighborhoods
regarding crime, drugs, access to healthy food, and adequate housing,
education and health care.123 Participants were urged to counteract the
deleterious effects of these conditions by engaging in prosocial activities
such as “grassroots activism, youth mentoring, crime-watch programs, and
status, and choice of drug); DeVall & Lanier, supra note 104, at 1109 (education, employment
status, and choice of drug); Gilbertson, supra note 104, at 18 (housing commissions of prior
property offenses).
118
Douglas B. Marlowe, Introduction to Identifying and Rectifying Racial, Ethnic, and
Gender Disparities in Treatment Courts, 1 J. ADVANCING JUST. 1, 2 (2018).
119
Douglas B. Marlowe et al., Developing a Culturally Proficient Intervention for Young
African American Men in Drug Court: Examining Feasibility and Estimating an Effect Size
for Habilitation Empowerment Accountability Therapy (HEAT), 1 J. ADVANC. JUST. 109, 111,
114 (2018).
120
Id. at 115–16.
121
Id. at 116.
122
Id.
123
Id.
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community cleanup.”124
While the pilot program was relatively small,125 its results were
extremely encouraging. Participants in HEAT were far more likely to
complete the program than those in control groups, and the Kentucky cohort
exceeded the overall statewide completion rate by more than twenty
percent.126 Other commentators have also encouraged culturally-sensitive
treatment to improve outcomes for participants of color. To that end,
Gallagher and Nordberg surveyed seventy African American drug court
participants to gain insight into whether certain practices enhanced or
undermined programmatic success.127 Respondents highlighted three areas
for improvement: more individualized mental health counseling; targeted job
skills training; and better relationships with treatment providers.128 With
respect to interpersonal interactions between participants and treatment
providers, respondents had a strongly negative reaction to labels such as
“addict” which they considered derogatory and stigmatizing but were
pressured to accept.129 Interestingly, HEAT did not require participants to
embrace such labels.130 Finding that African Americans’ success in drug
court was linked to their psychological well-being, McKean and WarrenGordon opined that hiring treatment providers of color would be especially
beneficial in this regard.131
V. THE OPIOID COURT ALTERNATIVE
In light of the interventions presently provided to opioid-addicted
offenders by drug courts, we must ask whether specialized opioid courts or
programs are truly necessary. Speaking in favor of this approach, Leigh
Saufley, the Chief Justice of the Maine Supreme Judicial Court, proposed
piloting a “full wrap-around drug court” dedicated to opioid addicts in her
state that would provide “immediate and extensive access to addiction
treatment, mental health treatment, sober housing, job training,
transportation, family-related services and long-term follow-up.”132 While
124

Id.
There were twenty-nine participants overall; ten from Lexington, Kentucky, and
nineteen from Indianapolis, Indiana. Marlowe et al., supra note 119, at 116, 120, 123.
126
Id. at 118, 12223.
127
John R. Gallagher & Anne Nordberg, African American Participants’ Suggestions for
Eliminating Racial Disparities in Graduation Rates: Implications for Drug Court Practice, 1
J. ADVANCING JUST. 89, 92 (2018).
128
Id. at 9598.
129
Id. at 95–96.
130
Marlowe et al., supra note 119, at 115 (noting that interventions focused instead “on
generic triggers for substance misuse and delinquent activity”).
131
McKean & Warren-Gordon, supra note 103, at 52.
132
Judy Harrison, Maine Chief Justice Proposes Expanding Drug Courts to Address
Opioid Crisis, BANGOR DAILY NEWS (Feb. 27, 2018), https://bangordailynews.com/2018/02/2
125
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these expanded services come with a hefty price tag,133 Chief Justice Saufley
considers the additional expenditure worth it, commenting that “[p]eople are
dying; families are hurting; [and] communities feel helpless.”134
Creating specialized courts or programs for opioid-addicted offenders
has one clear benefit: a guarantee of medication-assisted treatment. As
discussed previously, while MAT is critical to this group’s very survival,
many drug court judges remain skeptical of it, based on their longstanding
adherence to abstinence-only recovery models and negative associations
with methadone. Sadly, if Robert Lepolszki’s case had been managed in an
opioid court,135 he would probably still be alive today.
If jurisdictions create programs like the one Chief Justice Saufley
envisions, however, they must be careful to structure them in a way to
minimize racial inequities. HEAT and the Gallagher/Nordberg survey
provide a useful framework for the kinds of culturally-sensitive
considerations that courts should implement to enhance the graduation rates
of minority participants, particularly African Americans. Of course, to the
extent the opioid epidemic disproportionately affects Whites, opioid-specific
interventions will inevitably exacerbate whatever racial imbalance exists,
even if ameliorated by best practices.
While the “white face” of the opioid crisis has received much
journalistic attention,136 communities of color have not been immune to the
opioid crisis. Far from it. In a report issued in late 2017, the Chicago Urban
League notes that African Americans are dying from opioid overdose at rates
higher than Whites in a number of states, including Illinois.137 In fact, data
from the Illinois Department of Public Health show an increase in opioidrelated deaths of 132% among African Americans in Illinois between 2013
7/news/state/maine-chief-justice-proposes-expanding-drug-courts-to-address-opioid-crisis/.
133
The proposed court and its attendant services would cost an estimated five to seven
times as much as a traditional drug court. Id.
134
Id.
135
See supra text accompanying note 94.
136
See, e.g., Melissa Healy, Why Opioids Hit White Areas Harder: Doctors There
Prescribe More Readily, Study Finds, L.A. TIMES (Feb. 11, 2019),
https://www.latimes.com/science/sciencenow/la-sci-sn-opioids-whites-doctors-20190211story.html; Dennis Thompson, Poor Whites Bear the Brunt of the U.S. Opioid Crisis, Studies
Find, HEALTHDAY (Feb. 11, 2019), https://consumer.healthday.com/mental-healthinformation-25/addiction-news-6/poor-whites-bear-the-brunt-of-u-s-opioid-crisis-studiesfind-742626.html; All Things Considered, Why Is The Opioid Epidemic Overwhelmingly
White?, supra note 31.
137
Overdose rates were also higher for African Americans in Wisconsin, Missouri,
Minnesota, and West Virginia. See STEPHANIE SCHMITZ BECHTELER & KATHLEEN KANEWILLIS, CHI. URBAN LEAGUE RESEARCH & POLICY CTR., WHITEWASHED: THE AFRICAN
AMERICAN OPIOID EPIDEMIC 2 (2017), https://www.thechicagourbanleague.org/cms/lib/IL07
000264/Centricity/Domain/1/Whitewashed%20AA%20Opioid%20Crisis%2011-1517_EMBARGOED_%20FINAL.pdf.
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to 2016, accounting for 25% of all statewide opioid deaths, even though
African Americans make up only 15% of the state’s population.138 During
this period, overdose deaths from prescription pain pills tripled for Whites,
while increasing nine-fold for Illinois’ African Americans.139 Thus, while
greater numbers of Whites have died from opioid abuse across the country,
it is inaccurate to describe the crisis as primarily affecting only non-minority
communities.140
Finally, there is a more fundamental question about whether expanding
the role of the judiciary to manage opioid addiction is a wise strategy. In
recommending against the creation of opioid courts in Connecticut, a
statewide task force emphasized the high cost associated with this laborintensive approach which they believed would compromise the ability to
implement the model across jurisdictions.141 In addition, task force members
were not persuaded that opioid courts would achieve better long-term results
than the state’s existing “Treatment Pathway Program (TPP).”142 TPP,
which currently exists in four locations, releases opioid-addicted arrestees of
“less serious, non-violent drug or drug-related crimes” from custody and
provides community-based treatment and monitoring, including MAT.143
Based on data suggesting that TPP has been effective both in reducing costs
and helping addicts manage their addiction, the task force recommended
expanding the program statewide, an approach that better reflected
members’ preference for treating opioid addiction as a public health problem
with less “entanglement in the criminal justice system.”144
In the end, recommending a one-size-fits-all approach to managing the
opioid crisis is a fool’s errand. Jurisdictions vary widely in terms of available
resources and access to courts and treatment providers, among other things.
Opioid courts, or specialized programs located in drug courts for opioidaddicted offenders, have been effective in saving the lives of many and
putting them on more solid footing going forward. The results of
Connecticut’s diversionary TPP program are likewise impressive and offer
the added benefit, at least for some offenders, of removing the criminal
138

Id.
Id.
140
According to the Kaiser Family Foundation, blacks represented twelve percent of all
opioid-related overdose deaths in the United States in 2017, a percentage roughly proportional
to the African American population as a whole. Abdullah Shihipar, The Opioid Crisis Isn’t
White, N.Y. TIMES (Feb. 26, 2019), https://www.nytimes.com/2019/02/26/opinion/opioidcrisis-drug-users.html.
141
The task force’s report referenced, in this regard, the “resource-intensive” nature of
Buffalo’s Opioid Intervention Court. STATE OF CONN. JUDICIAL BRANCH, supra note 26, at
22.
142
Id. at 5.
143
Id. at 11–13.
144
Id. at 14–15, 22.
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justice system from the treatment program. Whatever path a jurisdiction
chooses, MAT is critical and culturally-sensitive strategies should be
employed to allow all those suffering from the scourge of opioid-addiction
to reclaim their lives.

